Matthew Sanzalone, MD
Pain Medicine · Saint Louis, MONPI 1467834820
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Abbott at 38.7% of the total. Reporting peaked in 2019 at $1,998 and has fallen 88.0% since, to $239 in 2025.
Across 89 payments — averaging $40.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Boston Scientific$895
- AbbVie$316
- Medtronic$315
- Collegium Pharmaceutical, Inc.$121
- Avanos Medical$107
- plus $426 from 12 others
What the payments were for
- Travel & lodging$1,61645%
- Food & beverage$1,94555%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $1,379 |
| Boston Scientific | 9 | $895 |
| AbbVie(2 entities) | 18 | $316 |
| Medtronic | 8 | $315 |
| Collegium Pharmaceutical, Inc. | 7 | $121 |
| Avanos Medical | 4 | $107 |
| Pfizer | 6 | $83 |
| Valinor Pharma, LLC | 3 | $54 |
| Nevro Corp. | 3 | $54 |
| Protega Pharmaceutials Inc | 2 | $43 |
| Biotronik NRO, Inc. | 2 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Stimwave Technologies Incorporated | 2 | $22 |
| Painteq LLC | 1 | $20 |
| Saluda Medical Americas, Inc. | 1 | $19 |
| Vertos Medical, Inc. | 1 | $15 |
| SPR Therapeutics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,561 in reported general payments places this provider in the 55th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levorphanol Tartrate | 11 | $35,999 |
| Pregabalin | 487 | $12,626 |
| Buprenorphine | 46 | $8,987 |
| Fentanyl | 21 | $5,476 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 204 | $4,140 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 110 | $3,892 |
| Oxycodone Hcl | 84 | $3,089 |
| Methocarbamol | 163 | $2,700 |
| Duloxetine Hcl | 126 | $2,642 |
| Gabapentin | 127 | $1,732 |
| Celecoxib | 76 | $1,569 |
| Lidocaine | 15 | $1,529 |
| Morphine Sulfate ErMorphine Sulfate | 36 | $975 |
| Baclofen | 70 | $957 |
| Morphine Sulfate | 20 | $943 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Saint Louis
- Vinicius Tieppo FrancioSaint Louis$35K
- Jooyoung MaengSaint Louis$25K
- Nabil AhmadSaint Louis$21K
- Katharine GurbaSaint Louis$18K
- Jeremy ThompsonSaint Louis$11K
- Alexander BeyzerSaint Louis$11K
- Hamed SadeghipourSaint Louis$10K
- Hess PanjetonSaint Louis$6K
- Xiaobin YiSaint Louis$6K
- Nicole ShinSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.